Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

/sup 99m/Tc-pyrophosphate bone scans and endocrinologic evaluation in a patient with eosinophilic granuloma

Journal Article · · N.C. Med. J.; (United States)
OSTI ID:7325963
Since its introduction in 1971, /sup 99m/Tc-pyrophosphate has become the radionuclide of choice in bone scanning. Its sensitivity in demonstrating bony metastases of malignant neoplasms is superior to other radionuclides such as /sup 87m/Sr and /sup 18/F. /sup 99m/Tc-pyrophosphate, however, is also concentrated in more benign lesions, such as fractures and secondary hypertrophic osteoarthropathy. Recently we evaluated a patient with eosinophilic granuloma, a disease not readily classified as either benign or malignant. The clinical data presented here emphasize the /sup 99m/Tc-pyrophosphate bone scan findings.
Research Organization:
Durham Veterans Administration Hospital, NC
OSTI ID:
7325963
Journal Information:
N.C. Med. J.; (United States), Journal Name: N.C. Med. J.; (United States) Vol. 36:10; ISSN NCMJA
Country of Publication:
United States
Language:
English